Melodiol Global Health (ASX:ME1DE) Operating Cash Flow per Share : A$-2.02 (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health Operating Cash Flow per Share?

Melodiol Global Health's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.40. Melodiol Global Health's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 51.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 46.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Melodiol Global Health's Operating Cash Flow per Share or its related term are showing as below:

ASX:ME1DE' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 4.3 Med: 34.7 Max: 51.7
Current: 51.7

During the past 8 years, Melodiol Global Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.70% per year. The lowest was 4.30% per year. And the median was 34.70% per year.

ASX:ME1DE's 3-Year OCF Growth Rate is ranked better than
88.35% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.4 vs ASX:ME1DE: 51.70

Melodiol Global Health Operating Cash Flow per Share Historical Data

The historical data trend for Melodiol Global Health's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Operating Cash Flow per Share Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-42.36

-15.57

-12.13

-7.08

-1.75

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial										-4.25	-2.83	-4.09	-1.62	-0.40

Competitive Comparison of Melodiol Global Health's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Melodiol Global Health's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Price-to-Operating-Cash-Flow falls into.

Melodiol Global Health Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Melodiol Global Health's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-8.141	/	4.647
	=	-1.75

Melodiol Global Health's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-2.261	/	5.661
	=	-0.40

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.02

Melodiol Global Health Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (ASX:ME1DE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DE) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

COPHF:USA

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DE) Headlines

No Headlines